HOOKIPA Pharma downgraded by RBC Capital Mkts with a new price target

12/20/24 7:37:05 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

RBC Capital Mkts downgraded HOOKIPA Pharma from Outperform to Sector Perform and set a new price target of $2.00 from $48.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$HOOK

Date	Price Target	Rating	Analyst
12/20/2024	$48.00 → $2.00	Outperform → Sector Perform	RBC Capital Mkts
11/15/2024	$50.00 → $48.00	Outperform	RBC Capital Mkts
12/2/2022		Neutral → Underperform	BofA Securities
2/17/2022	$15.00 → $8.00	Buy	HC Wainwright & Co.
2/16/2022	$3.00 → $4.00	Outperform	SVB Leerink
11/12/2021	$6.00	Overweight → Equal-Weight	Morgan Stanley
11/11/2021	$21.00 → $15.00	Buy	HC Wainwright & Co.
11/10/2021	$28.00 → $10.00	Outperform	SVB Leerink